Johnson & Johnson forecasts faster-than-expected growth through 2030
JNJ Johnson & Johnson
$256.48 -0.76%
View chart & analysis → - 1Johnson & Johnson completed the spin-off of its consumer health division in 2023.
- 2Johnson & Johnson proposed a $5.5 billion settlement under certain conditions.
- 3Tim Schmid, Executive Vice President and MedTech Chairman, expects Otava to have a significant financial impact by the end of the decade.
So what's the key point?
Johnson & Johnson has split its business divisions and proposed a $5.5 billion settlement. This decision is expected to have a major impact on the company's growth through 2030.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.